124 related articles for article (PubMed ID: 17702729)
21. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
[TBL] [Abstract][Full Text] [Related]
22. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease.
Kwan BC; Murtaugh MA; Beddhu S
Clin J Am Soc Nephrol; 2007 Sep; 2(5):992-8. PubMed ID: 17702712
[TBL] [Abstract][Full Text] [Related]
23. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
McCullough PA; Li S; Jurkovitz CT; Stevens L; Collins AJ; Chen SC; Norris KC; McFarlane S; Johnson B; Shlipak MG; Obialo CI; Brown WW; Vassalotti J; Whaley-Connell AT; Brenner RM; Bakris GL;
Am Heart J; 2008 Aug; 156(2):277-83. PubMed ID: 18657657
[TBL] [Abstract][Full Text] [Related]
24. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
[TBL] [Abstract][Full Text] [Related]
25. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
[TBL] [Abstract][Full Text] [Related]
26. A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS).
Bello AK; Peters J; Wight J; de Zeeuw D; El Nahas M;
Am J Kidney Dis; 2008 Sep; 52(3):434-43. PubMed ID: 18725014
[TBL] [Abstract][Full Text] [Related]
27. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
Collins AJ; Vassalotti JA; Wang C; Li S; Gilbertson DT; Liu J; Foley RN; Chen SC; Arneson TJ
Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S71-7. PubMed ID: 19231764
[TBL] [Abstract][Full Text] [Related]
28. Risk of development of chronic kidney disease in patients with type 2 diabetes having metabolic syndrome.
Moin S; Gondal GM; Bano U
J Coll Physicians Surg Pak; 2008 Aug; 18(8):472-6. PubMed ID: 18798582
[TBL] [Abstract][Full Text] [Related]
29. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
Wahba IM; Mak RH
Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
[TBL] [Abstract][Full Text] [Related]
30. What predicts the occurrence of the metabolic syndrome in a population-based cohort of adult healthy subjects?
Bo S; Rosato R; Ciccone G; Gambino R; Durazzo M; Gentile L; Cassader M; Cavallo-Perin P; Pagano G
Diabetes Metab Res Rev; 2009 Jan; 25(1):76-82. PubMed ID: 19145586
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion Diabetes (REDIA) Study.
Stengel B; Jaussent I; Guiserix J; Bourgeon B; Papoz L; Favier F;
Diabetes Metab; 2007 Dec; 33(6):444-52. PubMed ID: 18006351
[TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
Iseki K
J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
[TBL] [Abstract][Full Text] [Related]
33. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
[TBL] [Abstract][Full Text] [Related]
34. Renal manifestations in the metabolic syndrome.
Locatelli F; Pozzoni P; Del Vecchio L
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254
[TBL] [Abstract][Full Text] [Related]
35. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.
Chang Y; Ryu S; Sung E; Woo HY; Oh E; Cha K; Jung E; Kim WS
Metabolism; 2008 Apr; 57(4):569-76. PubMed ID: 18328362
[TBL] [Abstract][Full Text] [Related]
36. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.
Minutolo R; De Nicola L; Mazzaglia G; Postorino M; Cricelli C; Mantovani LG; Conte G; Cianciaruso B
Am J Kidney Dis; 2008 Sep; 52(3):444-53. PubMed ID: 18468747
[TBL] [Abstract][Full Text] [Related]
37. Risk of chronic kidney disease in hypertensive patients with other metabolic conditions.
Weycker D; Nichols GA; O'Keeffe-Rosetti M; Edelsberg J; Vincze G; Khan ZM; Oster G
J Hum Hypertens; 2008 Feb; 22(2):132-4. PubMed ID: 17728802
[TBL] [Abstract][Full Text] [Related]
38. The burden of chronic kidney disease in long-term liver transplant recipients.
de Boccardo G; Kim JY; Schiano TD; Maurette R; Gagliardi R; Murphy B; Emre S; Akalin E
Transplant Proc; 2008 Jun; 40(5):1498-503. PubMed ID: 18589138
[TBL] [Abstract][Full Text] [Related]
39. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
[TBL] [Abstract][Full Text] [Related]
40. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction.
Marquezine GF; Oliveira CM; Pereira AC; Krieger JE; Mill JG
Int J Cardiol; 2008 Sep; 129(2):259-65. PubMed ID: 18036678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
